SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-038882
Filing Date
2024-04-01
Accepted
2024-04-01 08:00:15
Documents
30
Period of Report
2024-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acst-20240401.htm   iXBRL 8-K 40248
2 EX-99.1 acst-ex99_1.htm EX-99.1 18178
3 GRAPHIC acst-ex99_1s1.jpg GRAPHIC 335702
4 GRAPHIC acst-ex99_1s2.jpg GRAPHIC 715573
5 GRAPHIC acst-ex99_1s3.jpg GRAPHIC 369124
6 GRAPHIC acst-ex99_1s4.jpg GRAPHIC 387913
7 GRAPHIC acst-ex99_1s5.jpg GRAPHIC 294207
8 GRAPHIC acst-ex99_1s6.jpg GRAPHIC 327369
9 GRAPHIC acst-ex99_1s7.jpg GRAPHIC 296969
10 GRAPHIC acst-ex99_1s8.jpg GRAPHIC 343456
11 GRAPHIC acst-ex99_1s9.jpg GRAPHIC 280860
12 GRAPHIC acst-ex99_1s10.jpg GRAPHIC 248369
13 GRAPHIC acst-ex99_1s11.jpg GRAPHIC 233366
14 GRAPHIC acst-ex99_1s12.jpg GRAPHIC 344861
15 GRAPHIC acst-ex99_1s13.jpg GRAPHIC 293311
16 GRAPHIC acst-ex99_1s14.jpg GRAPHIC 340474
17 GRAPHIC acst-ex99_1s15.jpg GRAPHIC 299344
18 GRAPHIC acst-ex99_1s16.jpg GRAPHIC 336734
19 GRAPHIC acst-ex99_1s17.jpg GRAPHIC 289837
20 GRAPHIC acst-ex99_1s18.jpg GRAPHIC 162272
  Complete submission text file 0000950170-24-038882.txt   8303577

Data Files

Seq Description Document Type Size
21 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acst-20240401.xsd EX-101.SCH 24881
33 EXTRACTED XBRL INSTANCE DOCUMENT acst-20240401_htm.xml XML 4701
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 24805612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)